Atlas Trials

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Clinical trial NCT03176485 · COMPLETED

Trial details

NCT number
NCT03176485
Sponsor
University of Arizona
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic CancerMelanomaColon CancerDifferentiated Thyroid CancerHepatocellular CarcinomaRenal Cell CarcinomaMetastatic MelanomaHCCMetastatic Colon Cancer
Start date
2014-10-17
Primary completion
2018-11-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.